-
Loading metrics
Open Access
Peer-reviewed
Research Article
Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T Lymphocytes
-
Shigeo Koido ,
* E-mail: shigeo_koido@jikei.ac.jp
Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan, Institute of Clinical Medicine and Research, The Jikei University School of Medicine, Tokyo, Japan, Department of Oncology, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Sadamu Homma,
Affiliation Department of Oncology, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Masato Okamoto,
Affiliation Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan
⨯ -
Yoshihisa Namiki,
Affiliation Institute of Clinical Medicine and Research, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Kazuki Takakura,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Akitaka Takahara,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Shunichi Odahara,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Shintaro Tsukinaga,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Toyokazu Yukawa,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Jimi Mitobe,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Hiroshi Matsudaira,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Keisuke Nagatsuma,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Kan Uchiyama,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Mikio Kajihara,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Seiji Arihiro,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Hiroo Imazu,
Affiliation Department of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Hiroshi Arakawa,
Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan, Department of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Shin Kan,
Affiliation Department of Oncology, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Hideo Komita,
Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan, Department of Oncology, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Masaki Ito,
Affiliation Department of Oncology, Institute of DNA Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Toshifumi Ohkusa,
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ -
Jianlin Gong,
Affiliation Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America
⨯ - [ ... ],
-
Hisao Tajiri
Affiliation Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
⨯ - [ view all ]
- [ view less ]
Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T Lymphocytes
- Shigeo Koido,
- Sadamu Homma,
- Masato Okamoto,
- Yoshihisa Namiki,
- Kazuki Takakura,
- Akitaka Takahara,
- Shunichi Odahara,
- Shintaro Tsukinaga,
- Toyokazu Yukawa,
- Jimi Mitobe
- Published: March 15, 2013
- https://doi.org/10.1371/journal.pone.0059280